{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:07:24Z","timestamp":1778252844549,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41433-022-02025-2","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:03:49Z","timestamp":1648515829000},"page":"714-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sebaceous gland carcinoma: analysis based on the 8th edition of American Joint Cancer Committee classification"],"prefix":"10.1038","volume":"37","author":[{"given":"Ashi","family":"Morawala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-4930","authenticated-orcid":false,"given":"Ashik","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Divya","family":"Jajapuram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-9961","authenticated-orcid":false,"given":"Swathi","family":"Kaliki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ophtha.2011.11.006","volume":"119","author":"B Esmaeli","year":"2012","unstructured":"Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119:1078\u201382.","journal-title":"Ophthalmology"},{"key":"2025_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/01676831003664343","volume":"30","author":"R Shinder","year":"2011","unstructured":"Shinder R, Ivan D, Seigler D, Dogan S, Esmaeli B. Feasibility of using American Joint Committee on Cancer Classification criteria for staging eyelid carcinomas. Orbit. 2011;30:202\u20137.","journal-title":"Orbit"},{"key":"2025_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/bjophthalmol-2013-303758","volume":"97","author":"A Watanabe","year":"2013","unstructured":"Watanabe A, Sun MT, Pirbhai A, Ueda K, Katori N, Selva D. Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes. Br J Ophthalmol. 2013;97:1459\u201363.","journal-title":"Br J Ophthalmol"},{"key":"2025_CR4","first-page":"779","volume-title":"AJCC Cancer Staging Manual","author":"B Esmaeli","year":"2017","unstructured":"Esmaeli B, Dutton JJ, Graue GF, Holbach LM, White VA, Coupland SE, et al. Eyelid carcinoma. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. (Eds.). AJCC Cancer Staging Manual. 8th edn. Switzerland: Springer International Publishing; 2017. p. 779\u201385.","edition":"8th edn."},{"key":"2025_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/IOP.0000000000001133","volume":"35","author":"S Ding","year":"2019","unstructured":"Ding S, Sagiv O, Guo Y, Kandl TJ, Thakar SD, Esmaeli B. Change in eyelid carcinoma T category with use of the 8th versus 7th edition of the American Joint Committee on Cancer: Cancer Staging Manual. Ophthalmic Plast Reconstr Surg. 2019;35:38\u201341.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2025_CR6","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1177\/1120672120936488","volume":"31","author":"F AlHammad","year":"2021","unstructured":"AlHammad F, Edward DP, Alkatan HM, Elkhamary S, Iuliano A, Maktabi A, et al. Eyelid sebaceous gland carcinoma: an assessment of the T classification of the American Joint Committee of Cancer TNM staging system 8th versus 7th edition. Eur J Ophthalmol. 2021;31:2055\u201363.","journal-title":"Eur J Ophthalmol"},{"key":"2025_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10792-016-0187-6","volume":"36","author":"S Kaliki","year":"2016","unstructured":"Kaliki S, Gupta A, Ali MH, Ayyar A, Naik MN. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification. Int Ophthalmol. 2016;36:681\u201390.","journal-title":"Int Ophthalmol"},{"key":"2025_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41433-019-0454-7","volume":"33","author":"Y Hsia","year":"2019","unstructured":"Hsia Y, Yeh CY, Wei YH, Chen LW, Liao SL. Eyelid sebaceous carcinoma: validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival. Eye (Lond). 2019;33:887\u201395.","journal-title":"Eye (Lond)"},{"key":"2025_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcjo.2020.07.017","volume":"56","author":"RR Reynolds","year":"2021","unstructured":"Reynolds RR, Davies MJ, Buffam FV, Dolman PJ, White VA. Differences in 7th and 8th edition American Joint Committee on Cancer staging for periocular sebaceous carcinoma. Can J Ophthalmol. 2021;56:31\u201336.","journal-title":"Can J Ophthalmol"},{"key":"2025_CR10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/bjophthalmol-2018-312635","volume":"103","author":"HS Sa","year":"2019","unstructured":"Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, et al. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol. 2019;103:980\u20134.","journal-title":"Br J Ophthalmol"},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2004.12.008","volume":"50","author":"JA Shields","year":"2005","unstructured":"Shields JA, Demirci H, Marr BP, Eagle RC Jr., Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50:103\u201322.","journal-title":"Surv Ophthalmol"},{"key":"2025_CR12","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ophtha.2004.07.031","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111:2151\u20137.","journal-title":"Ophthalmology"},{"key":"2025_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/bjophthalmol-2012-302443","volume":"97","author":"MM Muqit","year":"2013","unstructured":"Muqit MM, Foot B, Walters SJ, Mudhar HS, Roberts F, Rennie IG. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol. 2013;97:47\u201351.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02025-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T19:35:03Z","timestamp":1679859303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02025-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02025-2","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"8 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}